| 0ND | 表記: | [({[2-chloro-4-(1H-tetrazol-5-yl)phenyl]sulfonyl}amino)methyl]boronic acid | 組成式: | C8 H9 B Cl N5 O4 S | SMILES: | O=S(=O)(c2c(Cl)cc(c1nnnn1)cc2)NCB(O)O | InChi: | InChI=1S/C8H9BClN5O4S/c10-6-3-5(8-12-14-15-13-8)1-2-7(6)20(18,19)11-4-9(16)17/h1-3,11,16-17H,4H2,(H,12,13,14,15) | 定義日: | 2012-03-16 | 最終更新日: | 2024-09-27 | 公開日: | 2012-09-21 | 識別子(ID): | [({[2-chloro-4-(1H-tetrazol-5-yl)phenyl]sulfonyl}amino)methyl]boronic acid |
|
| HTR | 表記: | BETA-HYDROXYTRYPTOPHANE | 組成式: | C11 H12 N2 O3 | SMILES: | O=C(O)C(N)C(O)c2c1ccccc1nc2 | InChi: | InChI=1S/C11H12N2O3/c12-9(11(15)16)10(14)7-5-13-8-4-2-1-3-6(7)8/h1-5,9-10,13-14H,12H2,(H,15,16)/t9-,10-/m0/s1 | 定義日: | 1999-07-08 | 最終更新日: | 2024-09-27 | 識別子(ID): | (betaS)-beta-hydroxy-L-tryptophan |
|
| 0NE | 表記: | [({[4-(1H-tetrazol-5-yl)-2-(trifluoromethyl)phenyl]sulfonyl}amino)methyl]boronic acid | 組成式: | C9 H9 B F3 N5 O4 S | SMILES: | O=S(=O)(c2c(cc(c1nnnn1)cc2)C(F)(F)F)NCB(O)O | InChi: | InChI=1S/C9H9BF3N5O4S/c11-9(12,13)6-3-5(8-15-17-18-16-8)1-2-7(6)23(21,22)14-4-10(19)20/h1-3,14,19-20H,4H2,(H,15,16,17,18) | 定義日: | 2012-03-16 | 最終更新日: | 2024-09-27 | 公開日: | 2012-09-21 | 識別子(ID): | [({[4-(1H-tetrazol-5-yl)-2-(trifluoromethyl)phenyl]sulfonyl}amino)methyl]boronic acid |
|
| HTS | 表記: | 2-MERCAPTOPHENOL | 組成式: | C6 H6 O S | SMILES: | c1c(c(ccc1)S)O | InChi: | InChI=1S/C6H6OS/c7-5-3-1-2-4-6(5)8/h1-4,7-8H | 別名: | 2-HYDROXYTHIOPHENOL | 定義日: | 2007-02-27 | 最終更新日: | 2024-09-27 | 識別子(ID): | 2-sulfanylphenol |
|
| 0NG | 表記: | ({[(chloromethyl)sulfonyl]amino}methyl)boronic acid | 組成式: | C2 H7 B Cl N O4 S | SMILES: | ClCS(=O)(=O)NCB(O)O | InChi: | InChI=1S/C2H7BClNO4S/c4-2-10(8,9)5-1-3(6)7/h5-7H,1-2H2 | 定義日: | 2012-03-16 | 最終更新日: | 2024-09-27 | 公開日: | 2012-09-21 | 識別子(ID): | ({[(chloromethyl)sulfonyl]amino}methyl)boronic acid |
|
| HTU | 表記: | 4-sulfanylphenol | 組成式: | C6 H6 O S | SMILES: | Oc1ccc(S)cc1 | InChi: | InChI=1S/C6H6OS/c7-5-1-3-6(8)4-2-5/h1-4,7-8H | 定義日: | 2012-02-17 | 最終更新日: | 2024-09-27 | 公開日: | 2024-03-27 | 識別子(ID): | 4-sulfanylphenol |
|
| HTY | 表記: | (betaR)-beta-hydroxy-D-tyrosine | 組成式: | C9 H11 N O4 | SMILES: | O=C(O)C(N)C(O)c1ccc(O)cc1 | InChi: | InChI=1S/C9H11NO4/c10-7(9(13)14)8(12)5-1-3-6(11)4-2-5/h1-4,7-8,11-12H,10H2,(H,13,14)/t7-,8-/m1/s1 | 定義日: | 2002-09-02 | 最終更新日: | 2024-09-27 | 識別子(ID): | (betaR)-beta-hydroxy-D-tyrosine |
|
| IP8 | 表記: | Isopentenyl phosphate | 組成式: | C5 H11 O4 P | SMILES: | O=P(OCCC(=C)C)(O)O | InChi: | InChI=1S/C5H11O4P/c1-5(2)3-4-9-10(6,7)8/h1,3-4H2,2H3,(H2,6,7,8) | 別名: | 3-methylbut-3-en-1-yl dihydrogen phosphate | 定義日: | 2009-10-21 | 最終更新日: | 2024-09-27 | 識別子(ID): | 3-methylbut-3-en-1-yl dihydrogen phosphate |
|
| YIL | 表記: | N~2~-{[3-(acetamidomethyl)phenyl]acetyl}-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-carbamimidamido-1,1-dihydroxypentan-2-yl]-L-leucinamide | 組成式: | C30 H41 N7 O5 S | SMILES: | CC(=O)NCc1cccc(c1)CC(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(O)(O)c1nc2ccccc2s1 | InChi: | InChI=1S/C30H41N7O5S/c1-18(2)14-23(35-26(39)16-20-8-6-9-21(15-20)17-34-19(3)38)27(40)37-25(12-7-13-33-29(31)32)30(41,42)28-36-22-10-4-5-11-24(22)43-28/h4-6,8-11,15,18,23,25,41-42H,7,12-14,16-17H2,1-3H3,(H,34,38)(H,35,39)(H,37,40)(H4,31,32,33)/t23-,25-/m0/s1 | 定義日: | 2023-02-06 | 最終更新日: | 2024-09-27 | 公開日: | 2024-07-10 | 識別子(ID): | N~2~-{[3-(acetamidomethyl)phenyl]acetyl}-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-carbamimidamido-1,1-dihydroxypentan-2-yl]-L-leucinamide |
|
| IPD | 表記: | D-MYO-INOSITOL-1-PHOSPHATE | 組成式: | C6 H11 O9 P | SMILES: | O=P([O-])([O-])OC1C(O)C(O)C(O)C(O)C1O | InChi: | InChI=1S/C6H13O9P/c7-1-2(8)4(10)6(5(11)3(1)9)15-16(12,13)14/h1-11H,(H2,12,13,14)/p-2/t1-,2-,3+,4-,5-,6-/m1/s1 | 定義日: | 1999-07-08 | 最終更新日: | 2024-09-27 | 識別子(ID): | (1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl phosphate |
|
| IPI | 表記: | 3-methylbutylphosphonic acid | 組成式: | C5 H13 O3 P | SMILES: | CC(C)CC[P](O)(O)=O | InChi: | InChI=1S/C5H13O3P/c1-5(2)3-4-9(6,7)8/h5H,3-4H2,1-2H3,(H2,6,7,8) | 別名: | isoamylphosphonic acid | 定義日: | 2011-01-21 | 最終更新日: | 2024-09-27 | 識別子(ID): | 3-methylbutylphosphonic acid |
|
| HUD | 表記: | tert-butyl {(2S)-1-[(1R,2S,5S)-2-{[(2S,3R)-4-amino-1-cyclopropyl-3-hydroxy-4-oxobutan-2-yl]carbamoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hex-3-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate | 組成式: | C26 H44 N4 O6 | SMILES: | O=C(N3C(C(=O)NC(CC1CC1)C(O)C(=O)N)C2C(C)(C2C3)C)C(NC(=O)OC(C)(C)C)C(C)(C)C | InChi: | InChI=1S/C26H44N4O6/c1-24(2,3)19(29-23(35)36-25(4,5)6)22(34)30-12-14-16(26(14,7)8)17(30)21(33)28-15(11-13-9-10-13)18(31)20(27)32/h13-19,31H,9-12H2,1-8H3,(H2,27,32)(H,28,33)(H,29,35)/t14-,15-,16-,17-,18+,19+/m0/s1 | 別名: | ketoamide inhibitor SCH476776, bound form | 定義日: | 2007-01-08 | 最終更新日: | 2024-09-27 | 識別子(ID): | tert-butyl {(2S)-1-[(1R,2S,5S)-2-{[(2S,3R)-4-amino-1-cyclopropyl-3-hydroxy-4-oxobutan-2-yl]carbamoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hex-3-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate |
|
| IPP | 表記: | (P-IODOPHENYLACETYLAMINO)METHYLPHOSPHINIC ACID | 組成式: | C9 H11 I N O3 P | SMILES: | Ic1ccc(cc1)CC(=O)NCP(=O)O | InChi: | InChI=1S/C9H11INO3P/c10-8-3-1-7(2-4-8)5-9(12)11-6-15(13)14/h1-4,15H,5-6H2,(H,11,12)(H,13,14) | 定義日: | 1999-07-08 | 最終更新日: | 2024-09-27 | 識別子(ID): | (R)-({[(4-iodophenyl)acetyl]amino}methyl)phosphinic acid |
|
| HUJ | 表記: | [(1R)-3-methyl-1-[[1-[2-[(2,3,4-trimethoxyphenyl)carbonylamino]ethyl]-1,2,3-triazol-4-yl]carbonylamino]butyl]-tris(oxidanyl)boron | 組成式: | C20 H31 B N5 O8 | SMILES: | COc1ccc(C(=O)NCCn2cc(nn2)C(=O)N[CH](CC(C)C)[B](O)(O)O)c(OC)c1OC | InChi: | InChI=1S/C20H31BN5O8/c1-12(2)10-16(21(29,30)31)23-20(28)14-11-26(25-24-14)9-8-22-19(27)13-6-7-15(32-3)18(34-5)17(13)33-4/h6-7,11-12,16,29-31H,8-10H2,1-5H3,(H,22,27)(H,23,28)/t16-/m0/s1 | 定義日: | 2018-07-20 | 最終更新日: | 2024-09-27 | 公開日: | 2019-09-11 | 識別子(ID): | [3-methyl-1-[[1-[2-[(2,3,4-trimethoxyphenyl)carbonylamino]ethyl]-1,2,3-triazol-4-yl]carbonylamino]butyl]-tris(oxidanyl)boron |
|
| YJ2 | 表記: | (2S,4R)-1-[1-(4-BROMOPHENYL)CYCLOPROPYL]CARBONYL-4-(2-CHLOROPHENYL)SULFONYL-N-[1-(IMINOMETHYL)CYCLOPROPYL]PYRROLIDINE-2-CARBOXAMIDE | 組成式: | C25 H25 Br Cl N3 O4 S | SMILES: | O=S(=O)(c1ccccc1Cl)C5CC(C(=O)NC2(C=[N@H])CC2)N(C(=O)C4(c3ccc(Br)cc3)CC4)C5 | InChi: | InChI=1S/C25H25BrClN3O4S/c26-17-7-5-16(6-8-17)25(11-12-25)23(32)30-14-18(35(33,34)21-4-2-1-3-19(21)27)13-20(30)22(31)29-24(15-28)9-10-24/h1-8,15,18,20,28H,9-14H2,(H,29,31)/b28-15+/t18-,20+/m1/s1 | 定義日: | 2011-05-18 | 最終更新日: | 2024-09-27 | 識別子(ID): | (4R)-1-{[1-(4-bromophenyl)cyclopropyl]carbonyl}-4-[(2-chlorophenyl)sulfonyl]-N-[1-(iminomethyl)cyclopropyl]-L-prolinamide |
|
| 0OB | 表記: | 3-(1-benzothiophen-2-yl)propanoic acid | 組成式: | C11 H10 O2 S | SMILES: | O=C(O)CCc2sc1ccccc1c2 | InChi: | InChI=1S/C11H10O2S/c12-11(13)6-5-9-7-8-3-1-2-4-10(8)14-9/h1-4,7H,5-6H2,(H,12,13) | 定義日: | 2012-03-30 | 最終更新日: | 2024-09-27 | 公開日: | 2012-10-05 | 識別子(ID): | 3-(1-benzothiophen-2-yl)propanoic acid |
|
| YJ8 | 表記: | (2S,4R)-4-(2-chlorophenyl)sulfonyl-N-[1-(iminomethyl)cyclopropyl]-1-[1-(4-iodophenyl)cyclopropyl]carbonyl-pyrrolidine-2-carboxamide | 組成式: | C25 H25 Cl I N3 O4 S | SMILES: | O=S(=O)(c1ccccc1Cl)C5CC(C(=O)NC2(C=[N@H])CC2)N(C(=O)C4(c3ccc(I)cc3)CC4)C5 | InChi: | InChI=1S/C25H25ClIN3O4S/c26-19-3-1-2-4-21(19)35(33,34)18-13-20(22(31)29-24(15-28)9-10-24)30(14-18)23(32)25(11-12-25)16-5-7-17(27)8-6-16/h1-8,15,18,20,28H,9-14H2,(H,29,31)/b28-15+/t18-,20+/m1/s1 | 定義日: | 2011-05-19 | 最終更新日: | 2024-09-27 | 識別子(ID): | (4R)-4-[(2-chlorophenyl)sulfonyl]-N-[1-(iminomethyl)cyclopropyl]-1-{[1-(4-iodophenyl)cyclopropyl]carbonyl}-L-prolinamide |
|
| YJ9 | 表記: | (2S,4R)-4-(2-chlorophenyl)sulfonyl-N-[1-(iminomethyl)cyclopropyl]-1-[1-[4-(trifluoromethyl)phenyl]cyclopropyl]carbonyl-pyrrolidine-2-carboxamide | 組成式: | C26 H25 Cl F3 N3 O4 S | SMILES: | O=S(=O)(c1ccccc1Cl)C5CC(C(=O)NC2(C=[N@H])CC2)N(C(=O)C4(c3ccc(cc3)C(F)(F)F)CC4)C5 | InChi: | InChI=1S/C26H25ClF3N3O4S/c27-19-3-1-2-4-21(19)38(36,37)18-13-20(22(34)32-24(15-31)9-10-24)33(14-18)23(35)25(11-12-25)16-5-7-17(8-6-16)26(28,29)30/h1-8,15,18,20,31H,9-14H2,(H,32,34)/b31-15+/t18-,20+/m1/s1 | 定義日: | 2011-05-19 | 最終更新日: | 2024-09-27 | 識別子(ID): | (4R)-4-[(2-chlorophenyl)sulfonyl]-N-[1-(iminomethyl)cyclopropyl]-1-({1-[4-(trifluoromethyl)phenyl]cyclopropyl}carbonyl)-L-prolinamide |
|
| YJG | 表記: | 2-(5-chloro-6-oxopyridazin-1(6H)-yl)-N-(4-methyl-3-{[2-(pyridin-2-yl)ethyl]sulfamoyl}phenyl)acetamide | 組成式: | C20 H20 Cl N5 O4 S | SMILES: | O=C(CN1N=CC=C(Cl)C1=O)Nc1ccc(C)c(c1)S(=O)(=O)NCCc1ccccn1 | InChi: | InChI=1S/C20H20ClN5O4S/c1-14-5-6-16(25-19(27)13-26-20(28)17(21)8-10-23-26)12-18(14)31(29,30)24-11-7-15-4-2-3-9-22-15/h2-6,8-10,12,24H,7,11,13H2,1H3,(H,25,27) | 定義日: | 2021-03-10 | 最終更新日: | 2024-09-27 | 公開日: | 2021-03-17 | 識別子(ID): | 2-(5-chloro-6-oxopyridazin-1(6H)-yl)-N-(4-methyl-3-{[2-(pyridin-2-yl)ethyl]sulfamoyl}phenyl)acetamide |
|
| YJI | 表記: | N~3~-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-N-{2-[(2-hydroxyethyl)sulfanyl]ethyl}-beta-alaninamide | 組成式: | C13 H27 N2 O8 P S | SMILES: | O=C(NCCSCCO)CCNC(=O)C(O)C(C)(C)COP(=O)(O)O | InChi: | InChI=1S/C13H27N2O8PS/c1-13(2,9-23-24(20,21)22)11(18)12(19)15-4-3-10(17)14-5-7-25-8-6-16/h11,16,18H,3-9H2,1-2H3,(H,14,17)(H,15,19)(H2,20,21,22)/t11-/m0/s1 | 定義日: | 2023-02-08 | 最終更新日: | 2024-09-27 | 公開日: | 2023-06-14 | 識別子(ID): | N~3~-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-N-{2-[(2-hydroxyethyl)sulfanyl]ethyl}-beta-alaninamide |
|
| HUY | 表記: | 1-(2-{[3-(trifluoromethyl)phenyl]amino}phenyl)ethan-1-one | 組成式: | C15 H12 F3 N O | SMILES: | CC(c1ccccc1Nc2cccc(c2)C(F)(F)F)=O | InChi: | InChI=1S/C15H12F3NO/c1-10(20)13-7-2-3-8-14(13)19-12-6-4-5-11(9-12)15(16,17)18/h2-9,19H,1H3 | 定義日: | 2018-07-23 | 最終更新日: | 2024-09-27 | 公開日: | 2019-01-09 | 識別子(ID): | 1-(2-{[3-(trifluoromethyl)phenyl]amino}phenyl)ethan-1-one |
|
| IQ8 | 表記: | N-(2-acetamidoethyl)-4-(4,5-dihydro-1,3-thiazol-2-yl)benzamide | 組成式: | C14 H17 N3 O2 S | SMILES: | CC(=O)NCCNC(=O)c1ccc(cc1)C2=NCCS2 | InChi: | InChI=1S/C14H17N3O2S/c1-10(18)15-6-7-16-13(19)11-2-4-12(5-3-11)14-17-8-9-20-14/h2-5H,6-9H2,1H3,(H,15,18)(H,16,19) | 定義日: | 2022-07-08 | 最終更新日: | 2024-09-27 | 公開日: | 2023-09-27 | 識別子(ID): | ~{N}-(2-acetamidoethyl)-4-(4,5-dihydro-1,3-thiazol-2-yl)benzamide |
|
| YK3 | 表記: | tert-butyl [(6S,10P)-4-{4-[(ethanesulfonyl)amino]phenyl}-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetate | 組成式: | C25 H31 N5 O4 S2 | SMILES: | CCS(=O)(=O)Nc1ccc(cc1)C1=NC(CC(=O)OC(C)(C)C)c2nnc(C)n2c2sc(C)c(C)c21 | InChi: | InChI=1S/C25H31N5O4S2/c1-8-36(32,33)29-18-11-9-17(10-12-18)22-21-14(2)15(3)35-24(21)30-16(4)27-28-23(30)19(26-22)13-20(31)34-25(5,6)7/h9-12,19,29H,8,13H2,1-7H3/t19-/m0/s1 | 定義日: | 2023-02-09 | 最終更新日: | 2024-09-27 | 公開日: | 2023-03-08 | 識別子(ID): | tert-butyl [(6S,10P)-4-{4-[(ethanesulfonyl)amino]phenyl}-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetate |
|
| 0PC | 表記: | Nalpha-[(benzyloxy)carbonyl]-N-[(1S)-3-chloro-1-methyl-2-oxopropyl]-L-phenylalaninamide | 組成式: | C21 H23 Cl N2 O4 | SMILES: | ClCC(=O)C(NC(=O)C(NC(=O)OCc1ccccc1)Cc2ccccc2)C | InChi: | InChI=1S/C21H23ClN2O4/c1-15(19(25)13-22)23-20(26)18(12-16-8-4-2-5-9-16)24-21(27)28-14-17-10-6-3-7-11-17/h2-11,15,18H,12-14H2,1H3,(H,23,26)(H,24,27)/t15-,18-/m0/s1 | 別名: | ZPACK | 定義日: | 2008-09-14 | 最終更新日: | 2024-09-27 | 識別子(ID): | Nalpha-[(benzyloxy)carbonyl]-N-[(2S)-4-chloro-3-oxobutan-2-yl]-L-phenylalaninamide |
|
| YKA | 表記: | (1R,2S)-2-((S)-2-((((2-(4,4-difluorocyclohexyl)propan-2-yl)oxy)carbonyl)amino)-4-methylpentanamido)-1-hydroxy-3-((R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl)propane-1-sulfonic acid | 組成式: | C23 H37 F2 N3 O8 S | SMILES: | O=C1N=CCC1CC(NC(=O)C(CC(C)C)NC(=O)OC(C)(C)C1CCC(F)(F)CC1)C(O)S(=O)(=O)O | InChi: | InChI=1S/C23H37F2N3O8S/c1-13(2)11-16(28-21(32)36-22(3,4)15-5-8-23(24,25)9-6-15)19(30)27-17(20(31)37(33,34)35)12-14-7-10-26-18(14)29/h10,13-17,20,31H,5-9,11-12H2,1-4H3,(H,27,30)(H,28,32)(H,33,34,35)/t14-,16-,17-,20+/m0/s1 | 定義日: | 2021-03-11 | 最終更新日: | 2024-09-27 | 公開日: | 2021-03-24 | 識別子(ID): | (1R,2S)-2-{[N-({[2-(4,4-difluorocyclohexyl)propan-2-yl]oxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl]propane-1-sulfonic acid |
|